IMUNON Reports Strong Enrollment Momentum in Phase 3 OVATION 3 Trial of IMNN-001 in Advanced Ovarian Cancer
Globe Newswire•30/07/2026•09:00 ET
0
Whiz Insights
Get started
Create a free account to read the full story.
Create a free account to read the full story.